EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antidiabetic and Antihyperlipidemic Activities and Molecular Mechanisms of Phyllanthus emblica L. Extract in Mice on a High-Fat Diet

Hsing-Yi Lin, Cheng-Hsiu Lin, Yueh-Hsiung Kuo iD, Chun-Ching Shih iD

Current Issues in Molecular Biology · 20.09.2024 · 46 (9) · 10492-10529

DOI: 10.3390/cimb46090623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 20.09.2024. Verfasst von Hsing-Yi Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cheng Ching Hospital, No. 139, Pingdeng St., Central District, Taichung City 40045, Taiwan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the cooperation of Central Taiwan University of Science and Technology, Taichung, Taiwan, and Cheng Ching Hospital, Taichung, Taiwan, the cooperation of Central Taiwan University of Science and Technology, Taichung, Taiwan, and Cheng Ching Hospital Pingdeng Branch, Taichung, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We planned to explore the protective activities of extract of Phyllanthus emblica L. (EPE) on insulin resistance and metabolic disorders including hyperlipidemia, visceral obesity, and renal dysfunction in high-fat diet (HFD)-progressed T2DM mice. Mice treatments included 7 weeks of HFD induction followed by EPE, fenofibrate (Feno), or metformin (Metf) treatment daily for another 4-week HFD in HFD-fed mice. Finally, we harvested blood to analyze some tests on circulating glycemia and blood lipid levels. Western blotting analysis was performed on target gene expressions in peripheral tissues. The present findings indicated that EPE treatment reversed the HFD-induced increases in blood glucose, glycosylated HbA1C, and insulin levels. Our findings proved that treatment with EPE in HFD mice effectively controls hyperglycemia and hyperinsulinemia. Our results showed that EPE reduced blood lipid levels, including a reduction in blood triglyceride (TG), total cholesterol (TC), and free fatty acid (FFA); moreover, EPE reduced blood leptin levels and enhanced adiponectin concentrations. EPE treatment in HFD mice reduced BUN and creatinine in both blood and urine and lowered albumin levels in urine; moreover, EPE decreased circulating concentrations of inflammatory NLR family pyrin domain containing 3 (NLRP3) and kidney injury molecule-1 (KIM-1). These results indicated that EPE displayed antihyperglycemic and antihyperlipidemic activities but alleviated renal dysfunction in HFD mice. The histology examinations indicated that EPE treatment decreased adipose hypertrophy and hepatic ballooning, thus contributing to amelioration of lipid accumulation. EPE treatment decreased visceral fat amounts and led to improved systemic insulin resistance. For target gene expression levels, EPE enhanced AMP-activated protein kinase (AMPK) phosphorylation expressions both in livers and skeletal muscles and elevated the muscular membrane glucose transporter 4 (GLUT4) expressions. Treatment with EPE reduced hepatic glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) expressions to suppress glucose production in the livers and decreased phosphorylation of glycogen synthase kinase 3β (GSK3β) expressions to affect hepatic glycogen synthesis, thus convergently contributing to an antidiabetic effect and improving insulin resistance. The mechanism of the antihyperlipidemic activity of EPE involved a decrease in the hepatic phosphorylation of mammalian target of rapamycin complex C1 (mTORC1) and p70 S6 kinase 1 (S6K1) expressions to improve insulin resistance but also a reduction in hepatic sterol regulatory element binding protein (SREBP)-1c expressions, and suppression of ACC activity, thus resulting in the decreased fatty acid synthesis but elevated hepatic peroxisome proliferator-activated receptor (PPAR) α and SREBP-2 expressions, resulting in lowering TG and TC concentrations. Our results demonstrated that EPE improves insulin resistance and ameliorates hyperlipidemia in HFD mice.

Schlagwörter

Stichwörter der Autor:innen

Phyllanthus emblica L.antihyperlipidemicinsulin resistance

Autor:innen und Institutionen

  • Department of Internal Medicine, Cheng Ching Hospital, No. 139, Pingdeng St., Central District, Taichung City 40045, Taiwan.
  • Department of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City 42055, Taiwan.
  • Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung City 40402, Taiwan.
  • Department of Nursing, College of Nursing, Central Taiwan University of Science and Technology, No. 666 Buzih Road, Beitun District, Taichung City 40601, Taiwan.

ORCID-Profile: Yueh-Hsiung Kuo, Chun-Ching Shih

Förderung

  • the cooperation of Central Taiwan University of Science and Technology, Taichung, Taiwan, and Cheng Ching Hospital, Taichung, Taiwan
  • the cooperation of Central Taiwan University of Science and Technology, Taichung, Taiwan, and Cheng Ching Hospital Pingdeng Branch, Taichung, Taiwan

Zitieren

APA

Lin, H. Y., Lin, C. H., Kuo, Y. H., & Shih, C. C. (2024). Antidiabetic and Antihyperlipidemic Activities and Molecular Mechanisms of Phyllanthus emblica L. Extract in Mice on a High-Fat Diet. Current Issues in Molecular Biology, 46(9), 10492-10529. https://doi.org/10.3390/cimb46090623

Vancouver

Lin HY, Lin CH, Kuo YH, Shih CC. Antidiabetic and Antihyperlipidemic Activities and Molecular Mechanisms of Phyllanthus emblica L. Extract in Mice on a High-Fat Diet. Current Issues in Molecular Biology. 2024;46(9):10492-10529. doi:10.3390/cimb46090623

BibTeX
@article{Lin2024,
  author = {Lin, Hsing-Yi and Lin, Cheng-Hsiu and Kuo, Yueh-Hsiung and Shih, Chun-Ching},
  title = {Antidiabetic and Antihyperlipidemic Activities and Molecular Mechanisms of Phyllanthus emblica L. Extract in Mice on a High-Fat Diet},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {9},
  pages = {10492--10529},
  doi = {10.3390/cimb46090623}
}
Kostenlos starten →